Enabling new cell therapies with GMP-compliant multiparametric cell sorting [WEBINAR]

For more information, visit: https://www.miltenyibiotec.com/produc... Effective protocols for isolation and expansion of pan T cells for adoptive cell therapies have many persistent challenges with other effector cells, such as antigen-specific T Cells, tumor-infiltrating lymphocytes, or mesenchymal stem cells. One such challenge is the lack of a GMP-compliant platform for multiparametric enrichment. As treatments with these cell types for solid tumors and non-malignant diseases become more prevalent, improving such processes becomes more important.
In this roundtable discussion, we look at how a GMP-compliant flow cytometry-based cell sorting platform, the MACSQuant® Tyto® Cell Sorter, helps scientists in clinical and commercial settings enrich cells for use in clinical trials and research. After an introduction of the technology, key opinion leaders share their experiences using it.
Viewers will learn: which new options are available for the enrichment of effector cells for clinical use in adoptive cell therapies. About the benefits of the MACSQuant Tyto cell sorting technology and associated GMP-grade consumables and reagents and how the system helps advance clinical trials and research in commercial and academic settings.

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.